Wenshi Wang, based in Emeryville, CA, US, is currently a Vice President Cell therapy at Metagenomi, bringing experience from previous roles at Sangamo Therapeutics, Inc., Enochian BioSciences Inc, HemaCare Corporation and Kite Pharma, Inc.. Wenshi Wang holds a Immunology in infective diesease @ Ruprecht-Karls-Universität Heidelberg. With a robust skill set that includes Cancer Research, Cancer, Cell Biology, Cell Culture, In Vivo and more, Wenshi Wang contributes valuable insights to the industry. Wenshi Wang has 4 emails on RocketReach.